Ad is loading...
MIEGX
Price
$10.49
Change
-$0.08 (-0.76%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

MIEGX vs RNWFX

Header iconMIEGX vs RNWFX Comparison
Open Charts MIEGX vs RNWFXBanner chart's image
BNY Mellon Emerging Markets I
Price$10.49
Change-$0.08 (-0.76%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
MIEGX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MIEGX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIEGX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. MIEGX (203M). RNWFX pays higher dividends than MIEGX: RNWFX (1.51) vs MIEGX (1.30). MIEGX was incepted earlier than RNWFX: MIEGX (23 years) vs RNWFX (23 years). MIEGX is a more actively managed with annual turnover of: 121.64 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than MIEGX: RNWFX (250) vs MIEGX (10000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. MIEGX (7.64). RNWFX return over 5 years is better than : 17.17 vs. MIEGX (3.00).
MIEGXRNWFXMIEGX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD2.6427.09937%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRA10000N/A-
Net Assets203M60.9B0%
Annual Yield % from dividends1.301.5186%
Returns for 1 year7.6411.5466%
Returns for 3 years-19.31-14.55133%
Returns for 5 years3.0017.1717%
Returns for 10 years12.6041.0031%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics